Cargando…
Effect of Hydrocortisone vs Pasireotide on Pancreatic Surgery Complications in Patients With High Risk of Pancreatic Fistula: A Randomized Clinical Trial
IMPORTANCE: Both hydrocortisone and pasireotide have been shown in randomized clinical trials to be effective in reducing postoperative complications of pancreatic surgery, but to date no randomized clinical trial has evaluated the effectiveness of pasireotide compared with hydrocortisone. OBJECTIVE...
Autores principales: | Tarvainen, Timo, Sirén, Jukka, Kokkola, Arto, Sallinen, Ville |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042940/ https://www.ncbi.nlm.nih.gov/pubmed/32022887 http://dx.doi.org/10.1001/jamasurg.2019.6019 |
Ejemplares similares
-
Prediction and consequences of postoperative pancreatitis after pancreaticoduodenectomy
por: Bonsdorff, Akseli, et al.
Publicado: (2022) -
Development and external validation of DISPAIR fistula risk score for clinically relevant postoperative pancreatic fistula risk after distal pancreatectomy
por: Bonsdorff, Akseli, et al.
Publicado: (2022) -
Impact of pasireotide on postoperative pancreatic fistulas following distal resections
por: Vuorela, Tiina, et al.
Publicado: (2021) -
Pasireotide Versus Octreotide in Preventing Complications After Simultaneous Pancreas-Kidney Transplantation
por: Ahopelto, Kaisa, et al.
Publicado: (2023) -
Association of bacteria in pancreatic fistula fluid with complications after pancreatic surgery
por: Demir, E., et al.
Publicado: (2020)